Cell Transformation, Neoplastic
"Cell Transformation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Descriptor ID |
D002471
|
| MeSH Number(s) |
C04.697.098.500 C23.550.727.098.500
|
| Concept/Terms |
Cell Transformation, Neoplastic- Cell Transformation, Neoplastic
- Tumorigenic Transformation
- Transformation, Tumorigenic
- Transformations, Tumorigenic
- Tumorigenic Transformations
- Transformation, Neoplastic Cell
- Neoplastic Cell Transformation
- Cell Transformations, Neoplastic
- Neoplastic Cell Transformations
- Transformations, Neoplastic Cell
- Neoplastic Transformation, Cell
- Cell Neoplastic Transformation
- Cell Neoplastic Transformations
- Neoplastic Transformations, Cell
- Transformation, Cell Neoplastic
- Transformations, Cell Neoplastic
|
Below are MeSH descriptors whose meaning is more general than "Cell Transformation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Cell Transformation, Neoplastic".
This graph shows the total number of publications written about "Cell Transformation, Neoplastic" by people in this website by year, and whether "Cell Transformation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2013 | 3 | 0 | 3 |
| 2014 | 0 | 2 | 2 |
| 2018 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Transformation, Neoplastic" by people in Profiles.
-
Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells. Front Immunol. 2018; 9:2138.
-
KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation. Int J Cancer. 2018 10 15; 143(8):1994-2007.
-
?-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells. Sci Transl Med. 2014 Feb 26; 6(225):225ra28.
-
Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. Growth Factors. 2014 Feb; 32(1):41-52.
-
Interleukin 16 expression changes in association with ovarian malignant transformation. Am J Obstet Gynecol. 2014 Mar; 210(3):272.e1-10.
-
Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation. Cancer Res. 2013 Jun 01; 73(11):3248-61.
-
Ethanol-induced mast cell-mediated inflammation leads to increased susceptibility of intestinal tumorigenesis in the APC ?468 min mouse model of colon cancer. Alcohol Clin Exp Res. 2013 Jan; 37 Suppl 1:E199-208.
-
Organization, integration, and assembly of genetic and epigenetic regulatory machinery in nuclear microenvironments: implications for biological control in cancer. Ann N Y Acad Sci. 2009 Feb; 1155:4-14.
-
Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. Cancer Res. 2007 May 01; 67(9):4164-72.
-
Comparative analysis of imbalances in genomic DNA and mRNA expression levels in chondrosarcoma-derived cell line FSCP-1. Int J Oncol. 2004 Dec; 25(6):1651-60.